<DOC>
	<DOCNO>NCT00198094</DOCNO>
	<brief_summary>The primary objective study test hypothesis sertraline plus alprazolam XR result superior early stabilization primary care PD patient versus sertraline/placebo 12-week treatment period . The secondary objective study ) ass withdrawal symptom alprazolam XR taper ( week 5-7 12-week trial ) discontinuation , b ) compare physical health outcome , medical service utilization , cost-effectiveness two study intervention across 12-week treatment period subsequent three month maintenance treatment sertraline alone , c ) assess whether early co-administration sertraline/ alprazolam XR result great maintenance treatment response sertraline/placebo three month follow 12 week acute treatment program .</brief_summary>
	<brief_title>A Study Sertraline Early Alprazolam XR Administration Versus Sertraline Only Panic Disorder Patients</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Subjects include men woman age eighteen ; ability give write informed consent ; current principal coprincipal psychiatric diagnosis panic disorder without agoraphobia base DSMIV criterion ( American Psychiatric Association , 1994 ) ; willing use effective mean contraception ; free psychoactive medication least 2 week prior study enrollment ; actively suicidal . actively suicidal ; medical condition either sertraline alprazolam XR would contraindicate ; recent six month history substance alcohol abuse ; history presence psychotic bipolar disorder ; woman pregnant breastfeed ; history presence seizure disorder know history one childhood febrile seizure ; presence personality disorder severe enough compromise investigator 's ability evaluate efficacy safety study medication ; concomitant therapy psychotropic medication ( ) ; clinically significant abnormality physical examination , vital sign , EKG , urine drug screen , laboratory test screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>